Daniela Lenz

Ex Vivo Generation of CAR Macrophages from Hematopoietic Stem and Progenitor Cells for Use in Cancer Therapy

A. Schambach, Johann Meyer, T. Moritz, 2022, Cells.

Inducible Forward Programming of Human Pluripotent Stem Cells to Hemato-endothelial Progenitor Cells with Hematopoietic Progenitor Potential

A. Schambach, A. Schwarzer, Michael A. Morgan, 2019, Stem cell reports.

Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells

D. Steinemann, A. Schambach, F. Müller, 2017, Gene Therapy.

Genetic Correction of IL-10RB Deficiency Reconstitutes Anti-Inflammatory Regulation in iPSC-Derived Macrophages

D. Steinemann, A. Schambach, C. Klein, 2021, Journal of personalized medicine.

Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123

A. Schambach, M. Heuser, Michael A. Morgan, 2021, Viruses.

Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy.

C. von Kalle, A. Ganser, D. Wicke, 2012, Human gene therapy methods.

Rapid Isolation of Functional ex vivo Human Skin Tissue-Resident Memory T Lymphocytes

Jun Dong, A. Radbruch, A. Hauser, 2021, Frontiers in Immunology.